| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |